Prothena Corporation plc

PRTA ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $307.5M $471.4M $618.8M $710.4M $579.1M $295.4M $375.7M $427.7M
Accounts Receivable — $0 $5.2M $0 $0 $15.0K $68.0K $2.0K
Inventory — — — — — — — —
Total Current Assets $315.2M $485.4M $639.3M $719.1M $584.8M $299.3M $378.4M $431.4M
Property, Plant & Equipment $2.1M $3.1M $3.8M $1.7M $2.0M $2.6M $3.9M $52.8M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $326.8M $547.1M $696.4M $758.0M $609.4M $333.0M $419.3M $498.8M
Liabilities
Accounts Payable $5.9M $7.8M $25.4M $9.3M $3.7M $4.1M $1.2M $1.5M
Total Current Liabilities $40.8M $48.5M $56.9M $50.1M $33.5M $25.8M $17.7M $14.9M
Long-Term Debt — — — — — — — —
Total Liabilities $46.3M $60.2M $135.0M $136.0M $143.3M $149.0M $146.3M $175.8M
Stockholders' Equity
Retained Earnings $-1.35B $-1.10B $-980.0M $-833.0M $-716.1M $-783.0M $-671.9M $-598.0M
Total Stockholders' Equity $280.5M $486.9M $561.4M $622.0M $466.0M $184.0M $272.9M $323.0M
← Newer Page 1 of 2 Older →